FDA Cites Another Indian Drugmaker For Suspect Records
The U.S. Food and Drug Administration on Tuesday published a warning letter accusing Indian drugmaker Smruthi Organics Ltd. of bogus record-keeping surrounding production of active pharmaceutical ingredients, adding to several recent...To view the full article, register now.
Already a subscriber? Click here to view full article